Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • i19870503
    Junior Member
    • Aug 2014
    • 1

    some questions on cuffmerge and samtools flagstat output

    1.RNAseq is solid data mapped with bioscope, and I add XA tag manually to run cufflinks.
    when I use cuffmerge , it shows:Warning: couldn't find fasta record for 'chr1'! and so on.
    but I got merge.gtf, is there any different with normal output.

    2.I check the bam file with samtools flagstat, but I think there is something wrong
    54196276 + 0 in total (QC-passed reads + QC-failed reads)
    0 + 0 duplicates
    54196276 + 0 mapped (100.00%:-nan%)
    0 + 0 paired in sequencing
    0 + 0 read1
    0 + 0 read2
    0 + 0 properly paired (-nan%:-nan%)
    0 + 0 with itself and mate mapped
    0 + 0 singletons (-nan%:-nan%)
    0 + 0 with mate mapped to a different chr
    0 + 0 with mate mapped to a different chr (mapQ>=5)



    and also the samtools view output is here, did that mapped and sort correctly?
    @HD VN:1.0 SO:coordinate
    @SQ SN:chr1 LN:295529705 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:2cf1f3b70031dc473022a5a5893e8edb
    @SQ SN:chr2 LN:140133492 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:b709bf0683d1abdca4f6236a45524577
    @SQ SN:chr3 LN:123599780 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:2e896d4cc99e908405eb690a71467e37
    @SQ SN:chr4 LN:136254946 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:32ceede4917f4ea64a7ab93040211d21
    @SQ SN:chr5 LN:100516970 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:50bd953e6de61fb729390a122f830653
    @SQ SN:chr6 LN:123305171 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:2ed43939ee3490a30cbe40e96cf33289
    @SQ SN:chr7 LN:136409062 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:57ed74ddd703b537d8fece561887bcf4
    @SQ SN:chr8 LN:119985671 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:deadaedc161e58bf8c8d6b3ea1c25eba
    @SQ SN:chr9 LN:132468591 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:89eae5d26c774408170957bb006efbbd
    @SQ SN:chr10 LN:66736929 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:171e7a3f72ba195f457720406be3604b
    @SQ SN:chr11 LN:79814395 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:feeab3090c18a3cab9547f99d35052a8
    @SQ SN:chr12 LN:57431344 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:f3309f09ea225f9a191b5d0d9eee961d
    @SQ SN:chr13 LN:145235301 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:3a4b8ac5120541c225eb870fa4a2b501
    @SQ SN:chr14 LN:148510138 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:c607e774abadba7ed0b0185f18e3f9d5
    @SQ SN:chr15 LN:134541103 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:08f26a29f88b39bff614cd6fbfa7d2ef
    @SQ SN:chr16 LN:77435658 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:0f5873a922aa3327b4523def56cad5e6
    @SQ SN:chr17 LN:64395339 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:ac533e777ca34fe996fdf58598266b98
    @SQ SN:chr18 LN:54309914 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:1cc33aec4862e0d56e691e5dc5960501
    @SQ SN:chrX LN:125871292 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:d09f454e7e0e413bdd5e65af386c581d
    @SQ SN:chrM LN:16770 UR:file:/mnt/SolidPool/reference/genomes/susScr2/swine_susScr2_validated.fa M5:c32d2133c7327cc9e47776c5eed17977
    @RG ID:20121105185046758 LB:50F SM:SL002_251012_FC1_PG2_F3
    @PG ID:bioscope-genome-mapping VN:bioscope-1.2 CL:mapping.qual.pvalue=1; mapping.mismatch.penalty=-2.0; mapping.run.classic=false; mapping.qual.anchor.length=25; matching.max.hits=10; mapping.qual.filter.cutoff=0; mapping.classic.anchor.length=50; mapping.valid.adjacent=0; mapping.classic.mismatch=0; mapping.scheme.unmapped=25.2.0\:20; matching.use.iub.reference=false; mapping.qual.error.rate=0.2; mapping.qual.mismatch.level=3; mapping.qual.bvalue=1.0; read.length=50; mapping.scheme.repetitive=

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
215 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
79 views
0 reactions
Last Post SEQadmin2  
Working...